ClinicalTrials.Veeva

Menu

Phenotype/Genotype Correlation in a Family With Early Onset Osteoarthritis (Exorhum)

C

Caen University Hospital

Status

Completed

Conditions

Osteoarthritis

Treatments

Radiation: radiography (X-ray)
Genetic: DNA sampling

Study type

Observational

Funder types

Other

Identifiers

NCT01999166
2013-A00211-4

Details and patient eligibility

About

This study will investigate the genes responsible for osteoarthritis. Individuals with osteoarthritis known or suspected to be caused by a gene mutation (change) may be eligible for this study. Family members may also participate.

Patients will talk with investigators who will explain the study and its possible implications for the patient and family and answer questions. The patient's medical records will be reviewed, a personal and family history will be taken, and a physical examination will be done. Two procedures may be done including blood sampling (which will be used for DNA (genetic) studies) and X-rays (to define osteoarthritis grade).

If no known mutations responsible for osteoarthritis will be detected, participating family members will be interviewed by telephone about their personal and family health history and will have a blood sample drawn for DNA testing, and X-rays.

Full description

We will investigate the clinical manifestations and molecular genetic defects of human osteoarthritis. Families with osteoarthritis of known or suspected genetic basis will be enrolled. Individuals will undergo clinical assessment and genetic analyses for the purpose of: 1) definition and characterization of phenotype, 2) determination of the natural history of the disorder, and 3) genotype/phenotype correlation. Genetic linkage studies may be performed for disorders in which the genetic bases is not yet known.

Enrollment

5 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals (and family members) with early onset osteoarthritis according to the following definition:

    • symptomatic OA before 50 years old
    • no obvious causes of OA (IMC > 30, dysplasia,joint traumas)
    • at least three OA locations

Exclusion criteria

  • Individuals younger than 18 years old.

Trial design

5 participants in 1 patient group

Osteoarthritis
Treatment:
Genetic: DNA sampling
Radiation: radiography (X-ray)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems